Literature DB >> 4958341

Antibiotic prophylaxis and therapy of airborne tularemia.

W D Sawyer, H G Dangerfield, A L Hogge, D Crozier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4958341      PMCID： PMC378237          DOI： 10.1128/br.30.3.542-550.1966

Source DB:  PubMed          Journal:  Bacteriol Rev        ISSN： 0005-3678


× No keyword cloud information.
  12 in total

1.  Effect of antibiotics on intracellular Salmonella typhosa. II. Elimination of infection by prolonged treatment.

Authors:  H E HOPPS; J E SMADEL; B C BERNHEIM; J X DANAUSKAS; E B JACKSON
Journal:  J Immunol       Date:  1961-08       Impact factor: 5.422

2.  A MOBILE LABORATORY UNIT FOR EXPOSURE OF ANIMALS AND HUMAN VOLUNTEERS TO BACTERIAL AND VIRAL AEROSOLS.

Authors:  W R GRIFFITH
Journal:  Am Rev Respir Dis       Date:  1964-02

3.  Studies on human infection with Pasteurella tularensis; comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease.

Authors:  F R McCRUMB; M J SNYDER; T E WOODWARD
Journal:  Trans Assoc Am Physicians       Date:  1957

4.  Studies on Q fever in man.

Authors:  A S BENENSON; W D TIGERTT
Journal:  Trans Assoc Am Physicians       Date:  1956

5.  Immunization against scrub typhus. IV. Living Karp vaccine and chemoprophylaxis in volunteers.

Authors:  H L LEY; F H DIERCKS; P Y PATERSON; J E SMADEL; C L WISSEMAN; R TRAUB
Journal:  Am J Hyg       Date:  1952-11

6.  An apparatus for the study of airborne infection.

Authors:  D W HENDERSON
Journal:  J Hyg (Lond)       Date:  1952-03

7.  Further studies on tularemia in the Ozarks; review of forty-four cases during a three-year period.

Authors:  W C CORWIN; S P STUBBS
Journal:  J Am Med Assoc       Date:  1952-05-24

8.  Use of chloramphenicol (chloromycetin) in experimental and human tularemia.

Authors:  R T PARKER; L M LISTER; R E BAUER; H E HALL; T E WOODWARD
Journal:  J Am Med Assoc       Date:  1950-05-06

9.  Effect of aerosol age on the infectivity of airborne Pasteurella tularensis for Macaca mulatta and man.

Authors:  W D Sawyer; J V Jemski; A L Hogge; H T Eigelsbach; E K Wolfe; H G Dangerfield; W S Gochenour; D Crozier
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

10.  Intracellular infection and the carrier state.

Authors:  J E SMADEL
Journal:  Science       Date:  1963-04-12       Impact factor: 47.728
View more
  25 in total

1.  Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis.

Authors:  Luke C Kingry; Ryan M Troyer; Nicole L Marlenee; Helle Bielefeldt-Ohmann; Richard A Bowen; Alan R Schenkel; Steven W Dow; Richard A Slayden
Journal:  Microbes Infect       Date:  2010-11-09       Impact factor: 2.700

2.  Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.

Authors:  Michael A Pammit; Varija N Budhavarapu; Erin K Raulie; Karl E Klose; Judy M Teale; Bernard P Arulanandam
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Experimental tularemia in Macaca mulatta: relationship of aerosol particle size to the infectivity of airborne Pasteurella tularensis.

Authors:  W C Day; R F Berendt
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

4.  Exposure of laboratory workers to Francisella tularensis despite a bioterrorism procedure.

Authors:  Daniel S Shapiro; Donald R Schwartz
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Modeling inhalational tularemia: deliberate release and public health response.

Authors:  Joseph R Egan; Ian M Hall; Steve Leach
Journal:  Biosecur Bioterror       Date:  2011-11-01

6.  Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection.

Authors:  H T Eigelsbach; D H Hunter; W A Janssen; H G Dangerfield; S G Rabinowitz
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  Changes in whole blood and serum components of grivet monkeys with experimental respiratory Francisella tularensis infection.

Authors:  P Hambleton; A Baskerville; P W Harris-Smith; N E Bailey
Journal:  Br J Exp Pathol       Date:  1978-12

8.  The pathology of untreated and antibiotic-treated experimental tularaemia in monkeys.

Authors:  A Baskerville; P Hambleton; A B Dowsett
Journal:  Br J Exp Pathol       Date:  1978-12

9.  Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.

Authors:  Robin Ireland; Norma Olivares-Zavaleta; Jonathan M Warawa; Frank C Gherardini; Clayton Jarrett; B Joseph Hinnebusch; John T Belisle; Jeffery Fairman; Catharine M Bosio
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

10.  Pathogenesis of tularemia in monkeys aerogenically exposed to Francisella tularensis 425.

Authors:  R L Schricker; H T Eigelsbach; J Q Mitten; W C Hall
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.